High-calorie fatty diet for ALS patients
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a very high-calorie, fatty diet to see if it helps people with ALS. If you have been diagnosed recently and are not too advanced in the disease, this special diet may give your body extra energy to slow progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of ALS (possible, probable, or definite by standard criteria).
- Your first symptoms started less than 2 years ago.
- Your ALS has been getting worse at a certain rate (your doctor can check this with a quick formula).
- You are at least 18 years old.
- If you take ALS medications, you must have been on a steady dose for the last 4 weeks, or you cannot have taken them for at least 4 weeks.
- You do not already have a tracheostomy (tube in your windpipe) or are on a ventilator more than 22 hours a day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with ALS lose weight and what factors are involved. It follows patients in France and Germany to better understand weight changes and help improve care.
This study tests a supplement called acetyl-L-carnitine (ALCAR) to see if it can slow the progression of ALS. It is for people in the early stages of the disease who are already taking riluzole and have good lung and muscle function.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
This trial tests a traditional Chinese medicine made from cicada fungus for people with ALS who also have high levels of certain fats in their blood. The goal is to see if it can slow the disease and improve quality of life.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial tests whether a medicine called cyclophosphamide can slow the progression of ALS. It's given to people who have had symptoms for less than 2 years and still have good breathing, to see if calming the immune system can help protect nerve cells.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.